Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer
Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer
Recruiting · NCT07358182 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Trastuzumab-rezetecan in HER2-Expressing Breast Cancer | HER2-low Breast Cancer; HER2-positive Breast Cancer; Trastuzumab-rezetecan | Recruiting | Not stated | 2026-01-22 | NCT07358182 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou | China | 2 |